CIK 0001813814
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Definium Therapeutics, Inc.
Sign in to watch- Ticker
- DFTX
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 212-220-6633
- Business address
- ONE WORLD TRADE CENTER, SUITE 8500, NEW YORK, NY, 10007
- Former names
- Mind Medicine (MindMed) Inc.
- 3 Insider Initial Statement of Ownership
- 4/A Open-market sale Chief Executive Officer sold 18,948 shares at $0.71 ($13,453)
- 4 Shares withheld for taxes Chief Executive Officer gave up 18,948 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 13,038 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 19,110 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 10,203 shares (to pay taxes)
- 4 Grant or award Chief Legal Officer&Secretary acquired 1,200,000 shares (grant or award)
- 4 Grant or award Executive President acquired 600,000 shares (grant or award)
- 4 Grant or award Chief Medical Officer acquired 950,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 1,820,000 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Shares withheld for taxes Chief Executive Officer gave up 12,612 shares (to pay taxes)
- 4 Grant or award VP, Controller&Acct Principal acquired 403,430 shares (grant or award)
- 4 Shares withheld for taxes Chief Medical Officer gave up 118,143 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 18,734 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Executive Officer gave up 190,287 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 9 of 10 · 186 filings